Pluri, Inc. (PLUR)
1.29
+0.02
(+1.57%)
USD |
NASDAQ |
Sep 09, 16:00
1.29
0.00 (0.00%)
After-Hours: 19:07
Pluri Enterprise Value : 42.93M for Sept. 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 42.93M |
| September 04, 2026 | 43.87M |
| September 03, 2026 | 43.97M |
| September 02, 2026 | 44.50M |
| September 01, 2026 | 44.91M |
| August 31, 2026 | 45.02M |
| August 28, 2026 | 45.64M |
| August 27, 2026 | 45.64M |
| August 26, 2026 | 45.12M |
| August 25, 2026 | 47.00M |
| August 24, 2026 | 45.96M |
| August 21, 2026 | 47.52M |
| August 20, 2026 | 48.15M |
| August 19, 2026 | 48.04M |
| August 18, 2026 | 46.69M |
| August 17, 2026 | 46.37M |
| August 14, 2026 | 46.37M |
| August 13, 2026 | 47.01M |
| August 12, 2026 | 46.63M |
| August 11, 2026 | 47.94M |
| August 10, 2026 | 48.88M |
| August 07, 2026 | 48.67M |
| August 06, 2026 | 48.56M |
| August 05, 2026 | 47.83M |
| August 04, 2026 | 45.96M |
| Date | Value |
|---|---|
| August 03, 2026 | 46.11M |
| July 31, 2026 | 45.85M |
| July 30, 2026 | 45.96M |
| July 29, 2026 | 46.16M |
| July 28, 2026 | 47.21M |
| July 27, 2026 | 46.79M |
| July 24, 2026 | 48.25M |
| July 23, 2026 | 48.41M |
| July 22, 2026 | 48.98M |
| July 21, 2026 | 50.02M |
| July 20, 2026 | 48.67M |
| July 17, 2026 | 49.09M |
| July 16, 2026 | 48.46M |
| July 15, 2026 | 47.94M |
| July 14, 2026 | 47.21M |
| July 13, 2026 | 46.69M |
| July 10, 2026 | 47.57M |
| July 09, 2026 | 48.25M |
| July 08, 2026 | 49.50M |
| July 07, 2026 | 51.28M |
| July 06, 2026 | 52.42M |
| July 02, 2026 | 51.69M |
| July 01, 2026 | 51.48M |
| June 30, 2026 | 51.48M |
| June 29, 2026 | 52.11M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Compugen Ltd. | 120.22M |
| Evogene Ltd. | 8.679M |
| Scinai Immunotherapeutics Ltd. | 7.323M |
| CollPlant Biotechnologies Ltd. | 49.66M |
| Regentis Biomaterials Ltd. | 52.93M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.172M |
| Revenue (Quarterly) | 0.167M |
| Total Expenses (Quarterly) | 5.715M |
| EPS Diluted (Quarterly) | -0.5518 |
| Gross Profit Margin (Quarterly) | -43.11% |
| Profit Margin (Quarterly) | -3.70K% |
| Earnings Yield | -222.6% |
| Normalized Earnings Yield | -229.76 |